Geode Capital Management
KMTS icon

Geode Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Geode Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
647,380
+73,455
+13% +$1.54M ﹤0.01% 2270
2026
Q1 		$11.4M Buy
573,925
+154,810
+37% +$3.65M ﹤0.01% 2305
2025
Q4 		$11.1M Buy
419,115
+87,753
+26% +$2.26M ﹤0.01% 2366
2025
Q3 		$7.87M Buy
331,362
+6,036
+2% +$108K ﹤0.01% 2552
2025
Q2 		$5.4M Buy
325,326
+285,579
+718% +$6.23M ﹤0.01% 2690
2025
Q1 		$990K Buy
+39,747
New +$913K ﹤0.01% 3308

Other funds holding KMTS

Bain Capital Investors
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management's KMTS Position: Q2 2026 in Review

Geode Capital Management increased its Kestra Medical Technologies (KMTS) stake by 13% in Q2 2026, buying an estimated $1.54M and bringing the position to 647,380 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.

Geode Capital Management first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Geode Capital Management held 647,380 shares of Kestra Medical Technologies worth $16.5M as of Q2 2026.
  • Geode Capital Management bought 73,455 Kestra Medical Technologies shares in Q2 2026, an estimated $1.54M.
  • Kestra Medical Technologies made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2270 holding.
  • Geode Capital Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.